Connor, Clark & Lunn Investment Management (CC&L)
ABMD

Connor, Clark & Lunn Investment Management (CC&L)’s Abiomed Inc ABMD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45,648
Closed -$11.2M – 1487
2022
Q3 		$11.2M Buy
45,648
+26,711
+141% +$7.21M 0.07% 187
2022
Q2 		$4.69M Buy
+18,937
New +$5.11M 0.03% 323
2021
Q4 		– Sell
-4,263
Closed -$1.39M – 1248
2021
Q3 		$1.39M Sell
4,263
-2,220
-34% -$752K 0.01% 587
2021
Q2 		$2.02M Buy
6,483
+4,925
+316% +$1.51M 0.01% 539
2021
Q1 		$497K Buy
+1,558
New +$499K ﹤0.01% 796
2019
Q1 		– Sell
-6,046
Closed -$1.97M – 1073
2018
Q4 		$1.97M Sell
6,046
-20,779
-77% -$7.22M 0.01% 422
2018
Q3 		$12.1M Buy
26,825
+22,400
+506% +$8.83M 0.07% 197
2018
Q2 		$1.81M Buy
+4,425
New +$1.6M 0.01% 500

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ABMD Position: Q4 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 45,648 shares — an estimated $11.2M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ABMD in Q2 2018 and held it in 8 quarters. The position peaked at $12.1M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 45,648 Abiomed Inc shares in Q4 2022, an estimated $11.2M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Abiomed Inc in Q2 2018 and held it in 8 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Abiomed Inc position peaked at $12.1M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2022, filed 10 Feb 2023.